Search research articles
Contact Us
Filters
Showing results (221-230 of 294) with videos related to
Page
of 30
Sort By:
European Urology Oncology
|
April 22, 2023
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
Yi-Tsung Lu, Melissa Plets, Gareth Morrison, et al.
Nature Reviews. Urology
|
September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
European Urology
|
December 27, 2021
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer
Mathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, et al.
The Journal of Urology
|
March 20, 2010
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients
Derya Tilki, Oliver Reich, Robert S Svatek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Seth P Lerner, David J McConkey, Catherine M Tangen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study
Anita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
European Urology
|
July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)
Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
The Journal of Urology
|
July 21, 2009
p53 predictive value for pT1-2 N0 disease at radical cystectomy
Shahrokh F Shariat, Yair Lotan, Pierre I Karakiewicz, et al.
BJU International
|
September 11, 2025
Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy
Adnan Fazili, Seyed Behzad Jazayeri, Kyle M Rose, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 294) with videos related to
Sort By:
Page
of 30
European Urology Oncology
|
April 22, 2023
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
Yi-Tsung Lu, Melissa Plets, Gareth Morrison, et al.
Nature Reviews. Urology
|
September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
European Urology
|
December 27, 2021
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer
Mathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, et al.
The Journal of Urology
|
March 20, 2010
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients
Derya Tilki, Oliver Reich, Robert S Svatek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Seth P Lerner, David J McConkey, Catherine M Tangen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study
Anita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
European Urology
|
July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)
Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
The Journal of Urology
|
July 21, 2009
p53 predictive value for pT1-2 N0 disease at radical cystectomy
Shahrokh F Shariat, Yair Lotan, Pierre I Karakiewicz, et al.
BJU International
|
September 11, 2025
Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy
Adnan Fazili, Seyed Behzad Jazayeri, Kyle M Rose, et al.
Page
of 30